MC

MAPS Capital Management

North America, California, United States, San Ramon

Description

MAPS Capital provides C level executive services for startups, foreign companies seeking US presence, international marketing and business

Investor Profile

MAPS Capital Management has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MAPS Capital Management frequently co-invest with?

Modi Ventures
North America, Texas, United States, Houston
Co-Investments: 1
N
North America, California, United States, Santa Clara
Co-Investments: 1
Amgen
North America, California, United States, Thousand Oaks
Co-Investments: 1
March Capital
North America, California, United States, Santa Monica
Co-Investments: 1
Abu Dhabi Investment Authority
Asia, Abu Dhabi, United Arab Emirates, Abu Dhabi
Co-Investments: 1
Pictet Alternative Advisors
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by MAPS Capital Management?

Tongjia Hongrui Technology

Xihongmen, Beijing, China

Tongjia Hongrui Technology specializes in providing dry vacuum pump equipment and system technology services to the semiconductor sector.

IndustrialLaundry and Dry-cleaningManufacturing
Series CApr 7, 2025
Amount Raised: $68,666,699
Generate Biomedicines

Somerville, Massachusetts, United States

Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.

BiotechnologyHealth CareMedicalProduct Research
Series CSep 15, 2023
Amount Raised: $273,000,000